文献速递认知障碍与痴呆

症状前常染色体显性阿尔茨海默病的加速长期遗忘:一项横断面研究

Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
PubMed 文献 · Lancet Neurol · 2018-01-01

在伦敦大学学院痴呆研究中心的横断面研究中,21例常染色体显性阿尔茨海默病突变携带者与14例非携带者相比,7天回忆保留比例在列表、故事和图词任务中均较低,且越接近预期发病年龄加速长期遗忘越明显,携带者主观记忆评分也更差。

要点

  • 突变携带者7天回忆保留比例较非携带者低:列表低30.94个百分点、故事低20.10个百分点、图词低15.41个百分点。
  • 携带者7天再认记忆在全部任务中均低于非携带者,而初始学习与30分钟回忆无差异。
  • 加速长期遗忘可能是常染色体显性阿尔茨海默病症状前早期特征,或可解释主观记忆抱怨。

核心结论

  • 加速长期遗忘是常染色体显性阿尔茨海默病的早期症状前特征,似乎早于其他遗忘性缺陷出现,并可能构成阿尔茨海默病主观记忆抱怨的基础。
  • 作者认为加速长期遗忘测试可能对症状前阿尔茨海默病试验有用。

研究设计与样本

  • 横断面研究,地点为伦敦大学学院痴呆研究中心(英国伦敦),参与者来自已参与该中心研究的常染色体显性阿尔茨海默病家族队列。
  • 纳入标准为父母已知携带常染色体显性阿尔茨海默病突变且当前未报告认知下降症状;2015年2月17日至2016年3月30日共招募35人,其中21例为突变携带者(平均预期发病年限7.2年,SD 4.5)。
  • 评估列表、故事和图词三项任务的加速长期遗忘,比较7天回忆与初始学习及30分钟回忆,并评估7天再认;主观记忆采用日常记忆问卷评估。
  • 主要结局为每项任务中30分钟时保留材料在7天后被回忆的比例(即7天回忆除以30分钟回忆)。
  • 采用线性回归比较携带者与非携带者的加速长期遗忘评分(校正年龄、IQ和测试组),并评估携带者中加速长期遗忘与预期发病年限的关联;采用Spearman相关分析加速长期遗忘与主观记忆评分的关联。

主要发现

  • 三项任务的初始学习或30分钟回忆在携带者与非携带者之间均未检测到差异。
  • 7天回忆材料比例携带者低于非携带者:列表回忆平均差异-30.94个百分点(95%CI -45.16至-16.73;p=0.0002),故事回忆-20.10(-33.28至-6.91;p=0.0048),图词回忆-15.41(-26.88至-3.93;p=0.012)。
  • 携带者越接近预期发病年龄,加速长期遗忘越明显(三项测试均p≤0.01)。
  • 携带者7天再认记忆在全部任务中均较低:列表平均差异-5.80(95%CI -9.96至-2.47;p<0.01),故事-6.84(-10.94至-3.37;p<0.01),图词-17.61(-27.68至-7.72;p<0.01)。
  • 无症状携带者主观记忆评分较非携带者差(校正均数差7.88,95%CI 1.36至14.41;p=0.016),且在突变携带者中发现加速长期遗忘与主观记忆相关。

临床怎么用

  • 作者认为加速长期遗忘测试可能对症状前阿尔茨海默病试验有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tests sensitive to presymptomatic changes in Alzheimer's disease could be valuable for clinical trials. Accelerated long-term forgetting-during which memory impairment becomes apparent over longer periods than usually assessed, despite normal performance on standard cognitive testing-has been identified in other temporal lobe disorders. We assessed whether accelerated long-term forgetting is a feature of presymptomatic autosomal dominant (familial) Alzheimer's disease, and whether there is an association between accelerated long-term forgetting and early subjective memory changes. METHODS: This was a cross-sectional study at the Dementia Research Centre, University College London (London, UK). Participants were recruited from a cohort of autosomal dominant Alzheimer's disease families already involved in research at University College London, and had to have a parent known to be affected by an autosomal dominant Alzheimer's disease mutation, and not report any current symptoms of cognitive decline. Accelerated long-term forgetting of three tasks (list, story, and figure recall) was assessed by comparing 7-day recall with initial learning and 30-min recall. 7-day recognition was also assessed. Subjective memory was assessed using the Everyday Memory Questionnaire. The primary outcome measure for each task was the proportion of material retained at 30 min that was recalled 7 days later (ie, 7-day recall divided by 30-min recall). We used linear regression to compare accelerated long-term forgetting scores between mutation carriers and non-carriers (adjusting for age, IQ, and test set) and, for mutation carriers, to assess whether there was an association between accelerated long-term forgetting and estimated years to symptom onset (EYO). Spearman's correlation was used to examine the association between accelerated long-term forgetting and subjective memory scores. FINDINGS: Between Feb 17, 2015 and March 30, 2016, we recruited 35 people. 21 participants were mutation carriers (mean EYO 7·2 years, SD 4·5). Across the three tasks, we detected no differences between carriers and non-carriers for initial learning or 30-min recall. The proportion of material recalled at 7 days was lower in carriers than non-carriers for list (estimated difference in mean for list recall -30·94 percentage points, 95% CI -45·16 to -16·73; p=0·0002), story (-20·10, -33·28 to -6·91; p=0·0048), and figure (-15·41, -26·88 to -3·93; p=0·012) recall. Accelerated long-term forgetting was greater in carriers nearer to their estimated age at onset (p≤0·01 for all three tests). Mutation carriers' 7-day recognition memory was also lower across all tasks (list [mean difference -5·80, 95% CI -9·96 to -2·47; p<0·01], story [-6·84, -10·94 to -3·37; p<0·01], and figure [-17·61, -27·68 to -7·72; p<0·01] recognition). Subjective memory scores were poorer in asymptomatic carriers compared with non-carriers (adjusted difference in means 7·88, 95% CI 1·36 to 14·41; p=0·016), and we found a correlation between accelerated long-term forgetting and subjective memory in mutation carriers. INTERPRETATION: Accelerated long-term forgetting is an early presymptomatic feature of autosomal dominant Alzheimer's disease, which appears to pre-date other amnestic deficits and might underpin subjective memory complaints in Alzheimer's disease. Accelerated long-term forgetting testing might be useful in presymptomatic Alzheimer's disease trials. FUNDING: MRC, NIHR, Alzheimer's Research UK, Dementias Platform UK, Dunhill Medical Trust, ERUK, Great Western Research, Health Foundation, Patrick Berthoud Trust.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Weston PSJ, Nicholas JM, Henley SMD, et al. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study. Lancet Neurol. 2018. PMID: 29413314. doi:10.1016/S1474-4422(17)30434-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。